Innoviva Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
INVA Nasdaq 2834 http://www.inva.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Innoviva Inc

Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients With COPD - Apr 24th, 2018 10:55 am
Landmark IMPACT Study Published in NEJM Shows Significant Benefits of Trelegy Ellipta for Patients with COPD - Apr 18th, 2018 3:00 pm
See what the IHS Markit Score report has to say about Innoviva Inc. - Apr 16th, 2018 6:03 am
Biotech Stock Tests Buy Zone, Gets New Approval For Asthma Drug Relvar Ellipta - Apr 3rd, 2018 7:42 am
Flavor Of The Month: Innoviva And More - Mar 29th, 2018 8:02 am
March Growth Stock Opportunities - Mar 28th, 2018 10:02 am
Have Investors Priced In Innoviva Inc’s (NASDAQ:INVA) Growth? - Mar 9th, 2018 4:02 pm
GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma - Mar 8th, 2018 1:00 am
Report: Exploring Fundamental Drivers Behind Okta, Conduent, Innoviva, PRA Health Sciences, DDR, and Tenet Healthcare — New Horizons, Emerging Trends, and Upcoming Developments - Mar 6th, 2018 6:15 am
New Strong Sell Stocks for February 21st - Feb 21st, 2018 6:27 am
How Do Analysts See Innoviva Inc (NASDAQ:INVA) Performing In The Years Ahead? - Feb 19th, 2018 12:40 am
GSK Submits Landmark IMPACT Data to European Medicines Agency to Support Expanded Label for Trelegy Ellipta - Feb 14th, 2018 2:00 am
Why Innoviva Inc. Stock Jumped Tuesday - Feb 13th, 2018 2:05 pm
Sarissa Capital Reconstitutes Innoviva Board Of Directors - Feb 13th, 2018 9:38 am
Drug company Innoviva settles with activist hedge fund Sarissa -sources - Feb 12th, 2018 8:01 pm
Edited Transcript of INVA earnings conference call or presentation 8-Feb-18 10:00pm GMT - Feb 9th, 2018 12:09 pm